Clinical Trial Detail

NCT ID NCT03071276
Title Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Cytarabine + Fludarabine + Methotrexate + Prednisone + Selinexor

Age Groups: child adult

No variant requirements are available.